Local anesthetics are used in a wide range of clinical situations to prevent acute pain and to stop or ameliorate pain produced by cancer or pain associated with chronic painful conditions. Knowledge of the pharmacology of local anesthetics is essential for their safe use and selection of specific agents to achieve intended goals.
Introduction
Local anesthetics are widely used to prevent or treat acute pain; to treat inflammatory, cancer related, and chronic pain; and for diagnostic and prognostic purposes. Drugs classified as local anesthetics reversibly block action potential propagation in axons by preventing the sodium entry that produces the potentials [1] . Other actions of these drugs, however, such as anti-inflammatory actions by interaction with G-protein receptors [2] , are also thought to be relevant to their use to prevent or treat pain. Both nociceptive and neuropathic pain are targeted by this group of drugs. Any part of the nervous system, from the periphery to the brain, may be where local anesthetics act to produce a desired anesthetic or analgesic effect. A variety of formulations of local anesthetics, routes of administration, and methods of administration are used. The drugs are formulated commercially or by medical personnel according to intended route of administration or to address specific concerns or needs. In this article I provide a concise review of the pharmacology of local anesthetics with an emphasis on current concepts.
Chemistry
All local anesthetic molecules in clinical use have three parts: a lipophilic (aromatic) end, a hydrophilic (amine) end, and a link between the ends (Fig. 1 ). The link contains either an aminoester or an aminoamide bond, and local anesthetics are designated as belonging to one of two groups: aminoester-linked local anesthetics or aminoamide-linked local anesthetics. Procaine is the prototypic aminoester-linked local anesthetic, and lidocaine is the prototypic aminoamide-linked local anesthetic (Fig. 2) . Procaine was first synthesized in 1904 and lidocaine was first synthesized in 1943. Fundamental to the development of synthetic local anesthetics was isolation of cocaine from coca beans, and elucidation of its chemical structure. Synthesis of molecules with local anesthetic activity paved the way for 'tinkering' with the molecules by systematically modifying chemical structure and testing for a desired result, for example reduced toxicity, in order to develop new local anesthetics. Figure 3 presents a chronology of the introduction of local anesthetics into clinical practice. Four aminoester-linked local anesthetics appear in the figure -cocaine, procaine, tetracaine, and chloroprocaine. The other local anesthetics are aminoamide linked. What is evident from the figure is the focus since 1955 on the development of aminoamide-linked and not aminoester-linked local anesthetics. The reasons for this include the allergenic potential of aminoester-linked local anesthetics and the instability of aminoester bonds.
Testing various modifications to the basic procaine and lidocaine structure revealed that increasing the molecular weight of the molecules by adding carbon atoms to either end of the structure or to the link generally increases the lipid solubility, protein binding, duration of action and toxicity, and influences biotransformation of the molecule (Figs 4 and 5) [3] . There is a positive correlation between intrinsic local anesthetic potency and lipid solubility of local anesthetics.
Most local anesthetics have a tertiary amine on the hydrophilic end. Exceptions include prilocaine, which has a secondary amine, and benzocaine, which has a primary amine. Tertiary amines have a positive charge (cation) or are uncharged (base). The ratio of cation to base is determined by the pKa of the local anesthetic and the pH of the solution. The 'state' of the amine determines how well local anesthetic molecules move through biologic membranes. The unchanged forms of local anesthetics pass readily through cell membranes, and hence speed of onset of local anesthetic block, at least theoretically, is increased by increasing the concentration of uncharged local anesthetic molecules injected.
Local anesthetics are weak bases, and therefore increasing the pH ('alkalinization') of solution increases the ratio of base to cation. The Henderson-Hasselbach equation can be used to quantitate the ratio:
Log½ðcationÞ=ðbaseÞ ¼ pKaðlocal anestheticÞ À pHðsolutionÞ Sodium bicarbonate is used clinically to increase the pH of local anesthetic solutions.
Important to note is that commercial solutions of local anesthetics are acidified, so the hydrophilic (cationic) The newest additions to clinically available local anesthetics, namely ropivacaine ( Fig. 6 ) and levobupivacaine, represent the following: exploitation of technology that permits cost-favorable separation of racemic mixtures of local anesthetics into pure enantiomers; and the search for local anesthetics with greater safety margins. Simplistically stated, molecules with an asymmetric carbon atom exist in forms that are mirror images (i.e. exhibit 'handness', 'chirality'), with images (enantiomers, stereoisomers) distinguished by how they rotate light according to the orientation of the structures in three dimensions. Various terms are used to refer to the different enantiomers; I use S and R to designate two different enantiomers. A racemic mixture contains equal amounts of the R and S isomers. Commercial formulations of ropivacaine and levobupivacaine contain the S enantiomer. Note that levobupivacaine is the S form of bupivacaine. The motive for marketing pure enantiomers is evidence that the S form is less toxic, more potent, and longer acting than the R form or the racemic mixture (Table 1) .
Pharmacodynamics
Reversible block of voltage-gated sodium channels in axons is generally thought to be how local anesthetics 
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The aminoamide-linked local local anesthetics mepivacaine, ropivacaine, and bupivacaine vary only by substitution at R on the basic molecule. As the number of carbon atoms increases at R, potency, lipid solubility, and protein binding increase. Adapted from [4] . 
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Structural differences between procaine and tetracaine on the lipophilic (R 1 ) and hydrophilic end (R 2 ) markedly influence potency, toxicity, duration of action and hydrolysis rate. LD 50 , 50% lethal dose. 
R-ropivacaine
The only difference between the S and R-isomers of ropivacaine is their spatial orientation.
Table 1 Anesthetic duration and toxicity of local anesthetic isomers

Drug
Duration Toxicity There are a number of sodium channel subtypes that are generally divided into those that are tetrodotoxin sensitive and resistant [4] . Most sensory neurons generate tetrodotoxin-sensitive currents. Tetrodotoxin-resistant currents, however, are present in a high proportion of smaller dorsal root ganglion neurons associated with nociceptive A-d and C fibers. Available evidence indicates that channels from both groups are involved in pain states as a result of changes in channel function and expression caused by disease or injury. Arguments have been forwarded that local anesthetics might exert their pharmacologic action not only on sodium ion conductance, but also on other ionic conductances (e.g. potassium and calcium) [5, 6] .
Differential block, the block of pain perception without motor block for example, is observed clinically but the mechanism responsible for this is poorly understood. The clinical manifestations of differential block vary depending on the local anesthetic used [7] . For many years, differential block was ascribed to smaller axons being more sensitive than large ones to local anesthetics [8] , but this 'size principle' was challenged [9] . Berde and Strichartz [7] cited a number of different factors that might contribute to differential block, including anatomic factors and relative affinity of different local anesthetics for sodium and potassium channels. Oda et al. [10] suggested that preferential block of tetrodotoxin-resistent sodium channels by ropivacaine in small dorsal root ganglia neurons (associated with nociceptive sensation) underlies differential block observed during epidural anesthesia with this drug.
Another pharmacodynamic puzzle is the mechanism whereby systemically administered local anesthetic relieves pain. Analgesia effect has been reported following intravenous lidocaine administration in many acute and chronic conditions [11] [12] [13] [14] [15] [16] [17] [18] . Subcutaneously injected bupivacaine reportedly produces analgesia via a systemic effect [19] . Normal or altered sodium channels located in various areas of the brain, spinal cord, dorsal root ganglia, or in peripheral axons are mentioned most frequently as the action sites. Zhang et al. [20] reported that in rats systemic lidocaine delivered via implanted osmotic pump reduces sympathetic nerve sprouting in dorsal root ganglion that is associated with some neuropathic pain behaviors. Takatori et al. [21 ] presented evidence that inhibition of nerve growth factor-stimulated tyrosine kinase activity of TrkA (a high affinity receptor of nerve growth factor) might be involved in the suppression of neurite outgrowth by local anesthetics. Ligand-gated ion channels are channels whose permeability status depends upon the interaction between a ligand and a receptor that influences channel function. Many of these receptors interact with G proteins. Local anesthetics affect a number of biologic processes, including inhibition of Gprotein-coupled receptor signaling, which are potentially important pharmacodynamic actions that are of value in treating pain.
Pharmacokinetics
The usual pharmacokinetic parameters (Table 2) presented for drugs incompletely describe important details regarding distribution of local anesthetics from application sites to target and nontarget structures. It is well established that systemic absorption of local anesthetics correlates positively with the vascularity of the injection site (i.e. intravenous > tracheal > intracostal > paracervical > epidural > brachial plexus > sciatic > subcutaneous). The spinal cord meninges influence distribution of local anesthetics from the epidural and subarachnoid spaces. Intact skin is a near complete barrier to local anesthetic penetration. In the latter case, special local anesthetic formulations (e.g. EMLA cream -a eutectic mixture of lidocaine and prilocaine) or delivery methods (e.g. electrophoresis) are employedto facilitate transcutaneous transfer. The large number of different injection sites used by pain physicians (e.g. epidural, intrathecal, intrapleural, intraarticular, intramuscular, perineural, topical) and the variety of dosing methods (e.g. single shot, continuous infusion, intermittent infusion) make more than superficial discussion of the distribution kinetics of local anesthetics from injection sites beyond the scope of this review.
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Aminoester-linked local anesthetics are hydrolyzed by esterases in tissues and blood. Aminoamide-linked local anesthetics are biotransformed primarily in the liver by cytochrome P450 enzymes. Metabolites may retain local anesthetic activity and toxicity potential, albeit usually at lower potency than the parent compound.
Vasoconstrictors [e.g. epinephrine 1 : 400 000 (2.5 mg/ml)] are used to reduce absorption of local anesthetics into the systemic circulation. The value of doing so depends on vascularity of injection site and specific local anesthetic agent, which -among other considerations -vary in terms of intrinsic vasoactivity. The value of adding sodium bicarbonate to solutions to enhance speed of onset of local anesthetics also depends on injection site as well as physiochemical properties of the various local anesthetics. Addition of sodium bicarbonate increases the pH of solutions, which increases the ratio of uncharged to charged molecules. This increases the number of local anesthetic molecules in the form that most readily passes through biologic membranes. Hyaluronidase (tissue-spreading factor) is sometimes added to local anesthetic solutions to facilitate spread of solution at the injection site, thereby affecting speed of onset and extent of a block. This appears only to be useful when local anesthetic is injected behind the eyes in preparation for ophthalmologic surgery. Hyaluronidase may be injected with local anesthetic during epidural neurolysis to treat pain with positive benefit. A recent issue of Techniques in Regional Anesthesia and Pain Medicine [22] discussed in detail additives to local anesthetics.
Toxicity
The toxic effects of local anesthetics can be categorized as shown in Table 3 . True allergic reactions are associated with aminoester-linked local anesthetics, not aminoamidelinked ones. In a study of anaphylactic and anaphylactoid reactions (n ¼ 789) occurring during anesthesia, Mertes et al. [23] found no such reactions to local anesthetics. Mackley et al. [24] , however, reported that of 183 patients patch tested four had positive reactions to lidocaine, two of whom had histories of sensitivity to local injections of lidocaine manifested by dermatitis. They concluded that contact type IV sensitivity to lidocaine may occur more frequently than was previously thought.
It is common, but inappropriate, to refer to all adverse events as 'allergic reactions'. Tissue toxicity, primary myotoxicity, and neurotoxicity can be produced by all local anesthetics if 'high' concentrations are used. Signs and symptoms of varying degrees of neuropathy (e.g. transient neurologic symptoms, cauda equina syndrome) have been reported following spinal anesthesia with, for instance, 2% and 5% lidocaine. In a recent systematic review, Zaric et al. [25] compared the frequency of transient neurologic symptoms and neurologic complications after spinal anesthesia with lidocaine and with other local anesthetics. They found that the risk for developing transient neurologic symptoms after spinal anesthesia with lidocaine was higher with lidocaine than with bupivacaine, prilocaine, procaine, and mepivacaine. Symptoms in all patients disappeared spontaneously by the 10th postoperative day. The lithotomy position seems to be a predisposing factor. In 1980, Foster and Carlson [26] reported that, of the local anesthetics tested, procaine produces the least and bupivacaine the most severe muscle injury. More recently, Zink et al. [27] concluded that the myotoxic potential of ropivacaine is less than the potential of bupivacaine. Both drugs, however, produce morphologically identical patterns of calcified myonecrosis, formation of scar tissue, and a marked rate of muscle fiber regeneration in animals after continuous peripheral nerve blocks [28] .
A variety of local anesthetics may produce methemoglobinemia. Prilocaine is the local anesthetic for which there appears to be greatest risk for this to occur.
As the concentration of local anesthetic in the systemic circulation increases, various cardiovascular system and central nervous system signs and symptoms appear. The relative central nervous system and cardiovascular toxicity of local anesthetics has been of interest, especially after Albright [29] reported unexpected cardiovascular toxicity of bupivacaine. In animal studies, the ratio of doses of bupivacaine that produced convulsive activity and cardiovascular collapse [7] was lower than for other local anesthetics such as lidocaine. Human volunteer studies of doses required to produce early features of central nervous system and cardiovascular toxicity by ropivacaine and levo-bupivacaine demonstrated that the doses were about equal and were higher than for bupivacaine [30] [31] [32] .
Brown et al. [33] reviewed records of patients who had seizures while undergoing brachial plexus, epidural, and caudal regional anesthetics. No adverse cardiovascular, pulmonary, or nervous system events were associated Measures to prevent systemic toxic reactions to local anesthetics include following dose recommendations, injecting aliquots over time, avoiding inadvertent intravascular injections, and monitoring vital signs during injection. Blanket recommended doses versus block-specific recommended doses were recently discussed [34, 35] . Drug administration must be stopped should signs or symptoms of toxicity develop. Seizures induced by local anesthetics are usually self limiting, and require maintenance of respiratory gas exchange and control of muscle contractions (e.g. intubation, oxygenation, short-acting muscle paralysis). Drugs such as propofol, thiopental, and diazepam are effective against these seizures.
Cardiovascular toxicity is treated according to American Heart Association guidelines, depending on the nature of the toxicity. Recent evidence suggests that in some instances lipid emulsion infusion may be beneficial [36] . Data supporting the use of lipid emulsion relate to bupivacaine and may or may not apply to other local anesthetics [37 -42 ] . Consideration must be given to the cardiac effects of medications, such as propofol, when choosing a drug to treat local anesthetic-induced convulsions.
Conclusion
Local anesthetics are widely used to manage acute, chronic, and cancer pain and for diagnostic purposes. They have effects in addition to preventing sodium entry into axons that appear to contribute, at least in some instances, to their pain-relieving action. New formulations lead to prolonged action or to novel delivery approaches. Lipid emulsion reportedly is a new tool for treating bupivacaine cardiotoxicity.
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